Portfolio Diversification
Range
Most Diversified
20 instruments
January 1, 2022
Least Diversified
0 instruments
February 2, 2025
Average
19.6 instruments
Most Consistent Holdings
Top 5
PFE99.5%
NVAX99.5%
DVAX99.5%
ARCT99.5%
BNTX99.5%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Merck (MRK) | 6.44% | 5.92% | 99.29% | - |
 Vaxcyte (PCVX) | 6.36% | 3.63% | 99.15% | - |
| Arcturus Therapeutics (ARCT) | 6.1% | 2.61% | 99.5% | - |
| Novavax (NVAX) | 5.9% | 4.57% | 99.5% | - |
 Johnson & Johnson (JNJ) | 5.64% | 7.82% | 99.36% | - |
 Moderna (MRNA) | 5.61% | 3.67% | 99.43% | - |
| Dynavax (DVAX) | 5.42% | 4.66% | 99.5% | - |
 Sanofi (SNY) | 5.31% | 4.21% | 99.15% | - |
| BioNTech SE (BNTX) | 5.01% | 5.3% | 99.5% | - |
 Vir (VIR) | 4.73% | 3.46% | 99.5% | - |
| Pfizer (PFE) | 4.63% | 4.38% | 99.5% | - |
 Abbott (ABT) | 4.31% | 5.33% | 74.79% | - |
 CureVac (CVAC) | 4.22% | 5.98% | 99% | - |
 AstraZeneca (AZN) | 3.95% | 6.42% | 74.64% | - |
 Agenus (AGEN) | 2.87% | 0% | 75.85% | 1/2/2025 |
 Emergent BioSolutions (EBS) | 2.61% | 4.85% | 72.79% | - |
 GlaxoSmithKline (GSK) | 2.49% | 0% | 49.29% | 12/28/2023 |
 Maravai (MRVI) | 2.31% | 3.58% | 49.86% | - |
 Valneva (VLA.PA) | 2.26% | 6.98% | 50.21% | - |
 Vaxart (VXRT) | 2.05% | 2.12% | 48.36% | - |
 Inovio (INO) | 1.35% | 0% | 49.64% | 12/28/2023 |
 CanSino Biologics (6185.HK) | 1.24% | 0% | 26.5% | 1/2/2025 |
 Bavarian Nordic A/S (BAVA.CO) | 1.13% | 4.46% | 23.43% | - |
 Personalis (PSNL) | 1.08% | 7.41% | 23.08% | - |
 CSL (CSL.ASX) | 1.03% | 0% | 26.14% | 1/1/2025 |
 Takeda (TAK) | 0.94% | 0% | 24.93% | 12/28/2023 |
 OPKO Health (OPK) | 0.88% | 0% | 26.21% | 1/2/2025 |
 Allovir (KLRS) | 0.74% | 0% | 24.72% | 1/5/2023 |
 Invivyd (IVVD) | 0.69% | 0% | 24.36% | 1/5/2023 |
 VBI Vaccines (VBIVQ) | 0.64% | 0% | 24.72% | 1/5/2023 |
 GSK (GSK.L) | 0.01% | 0% | 0.36% | 1/5/2022 |
 Sanofi (SAN.PA) | 0.01% | 0% | 0.36% | 1/5/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
| Instrument | Invested | Value |
|---|---|---|
| Vaxcyte (PCVX) | 1.88% | 9.9% |
| Novavax (NVAX) | 15.45% | 8.86% |
| CanSino Biologics (6185.HK) | 3.53% | 7.58% |
| BioNTech SE (BNTX) | 6.83% | 6.35% |
| Abbott (ABT) | 3.67% | 5.93% |
| Merck (MRK) | 2.91% | 5.78% |
| Johnson & Johnson (JNJ) | 4.28% | 5.67% |
| AstraZeneca (AZN) | 3.35% | 5.01% |
| Dynavax (DVAX) | 2.91% | 4.91% |
| Maravai (MRVI) | 3.73% | 4.85% |
| Sanofi (SNY) | 2.87% | 4.38% |
| Pfizer (PFE) | 5.25% | 4.34% |
| Vir (VIR) | 7.69% | 4.3% |
| CSL (CSL.ASX) | 2.69% | 4.19% |
| OPKO Health (OPK) | 2.73% | 4.05% |
| CureVac (CVAC) | 8.22% | 3.88% |
| Arcturus Therapeutics (ARCT) | 3.58% | 3.83% |
| Moderna (MRNA) | 7.03% | 2.14% |
| Valneva (VLA.PA) | 2.71% | 2.1% |
| Agenus (AGEN) | 8.06% | 0.95% |